WO2000043020 EGG ANTI-INFLAMMATORY COMPOSITION AND METHOD OF TREATING AND PREVENTING INFLAMMATION

Settings

Stemming

Single Family Member

Include NPL

Feedback

Goto Application

Publication Number WO/2000/043020

Publication Date 27.07.2000

International Application No. PCT/US1999/030969

International Filing Date 28.12.1999

Chapter 2 Demand Filed 17.08.2000

IPC

CPC

View more classifications

View less classifications

Applicants

DCV, INC. [US]/[US]

Inventors

BECK, Lee, R.
ADALSTEINSSON, Orn
DALEY, Michael, J.
FITZPATRICK-MCELLIGOTT, Sandra
GREENBLATT, Hellen, Chaya
HUNCHAR, Jeffrey, G.
LEE, Young-Zoon
IYER, Subramanian
XING, Ruye

Agents

KRIKELIS, Basil, S.

Priority Data

09/233,379

19.01.1999

Publication Language English (en)

Filing Language English (EN)

Designated States

View all

Title

(EN) EGG ANTI-INFLAMMATORY COMPOSITION AND METHOD OF TREATING AND PREVENTING INFLAMMATION

(FR) COMPOSITION ANTI-INFLAMMATOIRE A BASE D'OEUF ET METHODE DE TRAITEMENT ET DE PREVENTION DE L'INFLAMMATION

Abstract

(EN) The invention is directed to a composition and method for the treatment and prevention of inflammation in general. The composition is an egg product obtained from an avian which has been hyperimmunized with no immunogenic mixture. The invention is further directed to an anti-inflammatory composition which has been partially purified from a hyperimmunized egg. The partially purified anti-inflammatory composition, when administered to a subject animal is effective in treating and preventing inflammation.

(FR) L'invention concerne une composition et une méthode de traitement et de prévention de l'inflammation en général. Ladite composition est un produit de l'oeuf, provenant d'un oiseau ayant été hyperimmunisé à l'aide d'un mélange immunogène. L'invention porte également sur une composition anti-inflammatoire ayant été partiellement purifiée, provenant d'un oeuf immunisé. La composition anti-inflammatoire partiellement purifiée, lorsqu'elle est administrée à un sujet animal, est efficace dans le traitement et la prévention de l'inflammation.

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35	Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12	Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
48	Reproductive organs
54	Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35	Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12	Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
48	Reproductive organs
54	Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
505	comprising antibodies

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
505	comprising antibodies
507	Comprising a combination of two or more separate antibodies

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
54	characterised by the route of administration
541	Mucosal route
542	oral/gastrointestinal

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. WO2000043020 - EGG ANTI-INFLAMMATORY COMPOSITION AND METHOD OF TREATING AND PREVENTING INFLAMMATION

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system
16	for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
K	PEPTIDES
16	Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
02	from eggs

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
K	PEPTIDES
16	Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
12	against material from bacteria
1203	from Gram-negative bacteria
1228	from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
K	PEPTIDES
16	Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
12	against material from bacteria
1203	from Gram-negative bacteria
1228	from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
1232	from Escherichia (G)

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
K	PEPTIDES
16	Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
12	against material from bacteria
1203	from Gram-negative bacteria
1228	from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
1235	from Salmonella (G)